GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Barak Investment House Ltd (XTAE:BARI) » Definitions » Debt-to-Revenue

Barak Investment House (XTAE:BARI) Debt-to-Revenue : N/A (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Barak Investment House Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Barak Investment House's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪15.51 Mil. Barak Investment House's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₪20.88 Mil. Barak Investment House's annualized Revenue for the quarter that ended in Dec. 2023 was ₪0.00 Mil.


Barak Investment House Debt-to-Revenue Historical Data

The historical data trend for Barak Investment House's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Barak Investment House Debt-to-Revenue Chart

Barak Investment House Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial 0.03 0.24 0.34 0.99 1.86

Barak Investment House Quarterly Data
Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.69 1.73 N/A N/A

Competitive Comparison of Barak Investment House's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Barak Investment House's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Barak Investment House's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Barak Investment House's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Barak Investment House's Debt-to-Revenue falls into.



Barak Investment House Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Barak Investment House's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(15.505 + 20.881) / 19.588
=1.86

Barak Investment House's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(15.505 + 20.881) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Barak Investment House Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Barak Investment House's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Barak Investment House (XTAE:BARI) Business Description

Traded in Other Exchanges
N/A
Address
Jabotinsky Street 7, Ramat Gan, ISR, 52520
Panaxia Labs Israel Ltd is engaged in the manufacture and distribution of medical cannabis products. The firm offers a wide range of products comprising oral tablets, sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches.

Barak Investment House (XTAE:BARI) Headlines

No Headlines